S. 369, The Preserve Access to Affordable Generics Act (8 wiki edits: view article ↓)

  • This item is from the 111th Congress (2009-2010) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
  • This bill, or a similar bill, was reintroduced in the current Congress as S. 27, The Preserve Access to Affordable Generics Act.

S. 369 would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.

(

Learn More

From the Blog

WashingtonWatch.com Digest – February 1, 2010

This is the WashingtonWatch.com email newsletter for the week of February 1, 2010. Subscribe here. email newsletter | tell a friend | wiki | about | home | log in From the Blog: President Obama Wants Earmark Transparency In his State of th...

Visitor Comments Comments Feed for This Bill

There are currently no comments for this bill

RSS Feeds for This Bill

Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)